Τα καλύτερα Viral Hepatitis podcast (2024)

1
How to Make Depression Care an Integral Part of HIV Care 50:58

6h ago50:58

50:58

In this episode, Bradley N. Gaynes, MD, MPH, and Glenn J. Treisman, MD, PhD, discuss the importance of screening, diagnosing, and treating depression in people living with HIV. They illustrate their discussion through a patient case and provide strategies for accomplishing this, including creation of a virtual network and employment of measurement-…

1
Managing Weight Gain on ART 24:00

28d ago24:00

24:00

In this episode, Cristina Mussini, MD,and William R. Short, MD, MPH, FIDSA,discuss the potential role of ART in weight change among people living with HIV. Listen to their conversation on whether ART switch can lead to weight loss after weight gain and how to counsel people living with HIV on weight loss options, including lifestyle modifications a…

1
A Triumphant Return: Welcoming People Back to HIV Care 12:33

1M ago12:33

12:33

In this episode, Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD, uses a case study to illustrate why patients living with HIV may disengage with their care and how best to reengage them once they present at the clinic, including discussion of: The valid reasons patients have for disengaging with their HIV care Why the return to care should be c…

1
Mpox: Making Vaccination Routine 13:49

1M ago13:49

13:49

In this second podcast of our series, hear expert faculty explore the CDC recommendations for mpox protection and discuss how vaccination can lead to immunologic equity. Topics include: Should we consider mpox an STI? What strategies can be used to improve mpox vaccination and overcome the challenges of vaccine implementation? Can mpox vaccine be c…

1
Mpox Infection and Prevention 19:41

1M ago19:41

19:41

Hear expert faculty answer common questions about the risk, impact, and recommendations for protection against mpox, including: Why is mpox relevant to clinical practice? Who is at highest risk for mpox? How is mpox transmitted, and what are the clinical manifestations and complications of mpox infections? What are current ACIP recommendations for …

1
Monica Gandhi, MD, MPH - Adapting HIV Treatment for People With Substance Use Disorder 48:01

1M ago48:01

48:01

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CE/AAPA information, and to apply for credit, please visit us at PeerView.com/VCQ865. CME…

1
Monica Gandhi, MD, MPH - Adapting HIV Treatment for People With Substance Use Disorder 47:30

1M ago47:30

47:30

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CE/AAPA information, and to apply for credit, please visit us at PeerView.com/VCQ865. CME…

1
Breaking Down Key PrEP Barriers: Patient and Regimen-Based Factors 11:50

2M ago11:50

11:50

In this episode, Roger Bedimo, MD, MS, FACP, examines patient and regimen-based PrEP barriers and discusses practical interventions to support PrEP adherence in key populations. Topics covered include: Individual and community perspectives on PrEP barriers Key barriers by principal populations Strategies to support PrEP delivery PrEP options for ke…

1
Actively Countering Health Disparities to Improve PrEP Uptake 15:09

2M ago15:09

15:09

In this episode, Roger Bedimo, MD, MS, FACP, discusses strategies to overcome health disparities to improve PrEP uptake, including: Targeting key populations that would benefit from PrEP but have low rates of uptake, such as transgender women and people who inject drugs Addressing intersectionality Overcoming implicit bias Addressing PrEP inequity …

1
Addressing Provider and Structural PrEP Barriers 14:40

2M ago14:40

14:40

In this episode, Roger Bedimo, MD, MS, FACP, examines provider-based and structural PrEP barriers and discusses practical methods for healthcare professionals to overcome these challenges. Topics covered include: Potential provider barriers to prescribing PrEP Strategies to facilitate conversations about PrEP Addressing the gap in PrEP provider tra…

1
Proactively Considering if Each Person Is on the Right HIV ART Regimen for Them 21:26

2M ago21:26

21:26

In this episode, Tristan J. Barber, MA, MD, FRCP, and Roger Bedimo, MD, MS, FACP, help you decide whether and how to modify ART in virologically suppressed individuals by critically appraising whether using newer agents may improve their treatment satisfaction. Listen to their conversation about their own approaches to evaluating whether each perso…

1
HIV Monitoring for People Receiving Long Acting PrEP 5:38

3M ago5:38

5:38

In this episode, Jonathan Appelbaum, MD, FACP, AAHIVS, discusses the updated CDC guidance on how to monitor for HIV in people receiving PrEP, including: Rationale for why HIV monitoring differs for people receiving LA vs daily PrEP Description of LEVI syndrome How to transition a person from LA PrEP to HIV ART if they test positive for HIV Presente…

1
Studies of LA ART in People With Adherence Challenges or Viremia 9:36

3M ago9:36

9:36

In this episode, Jonathan Appelbaum, MD, FACP, AAHIVS, discusses the newest data supporting LA ART use in people with adherence challenges or viremia, including: The LATITUDE study, an open-label phase III study of LA CAB + RPV in people with a suboptimal response or nonadherence to oral ART Updates to the Ward 86 cohort, which showed 81% of patien…

1
Simplifying RSV Vaccination: Expert Q&A 9:27

3M ago9:27

9:27

In this episode, Angela Branche, MD, FIDSA, and Jewel Mullen, MD, MPH, MPA, FACP, address commonly asked questions about the RSV vaccine, including: Considerations for vaccine eligibility Recommendations for pregnant persons Vaccine administration based on RSV seasonality Use of the vaccine in persons receiving immunosuppressive medications Safety …

1
Implementing RSV Vaccines Into Practice 11:50

3M ago11:50

11:50

In this episode, Jewel Mullen, MD, MPH, MPA, FACP, discusses strategies for implementing RSV vaccines into practice, with an emphasis on: Understanding the reasoning for Advisory Committee on Immunization Practices RSV vaccine recommendations Factors that influence vaccine uptake and patient decision-making Considerations for patient and healthcare…

1
Understanding Risk Factors for Severe RSV Disease 14:06

3M ago14:06

14:06

In this episode, Angela Branche, MD, FIDSA, explores the burden of RSV disease in older adults, including: RSV seasonality and disease burden Symptoms and complications of RSV infection Older age as a key risk factor for severe RSV disease and complications (eg, pneumonia, hospitalization) Comorbidities associated with increased risk of RSV hospita…

1
Optimizing Shingles Vaccine Uptake 47:53

3M ago47:53

47:53

Using common case scenarios, Robert H. Hopkins, Jr., MD, MACP, and Laura P. Hurley, MD, MPH, discuss strategies for optimizing shingles vaccine uptake, including: The pathophysiology of shingles to better understand risk and burden CDC guidelines and ACIP shingles vaccine recommendations, including considerations for those who are immunocompromised…

1
Integrating New Data From CROI 2024: Pharmacist Perspectives 27:52

3M ago27:52

27:52

In this episode, Samantha Strong, PharmD, BCACP, AAHIVP, CDCES, and Nimish Patel, PharmD, PhD, AAHIVP, cover the most impactful clinical studies presented at CROI 2024, including: New data on long-acting ART, including: The CARES study of LA CAB + RPV in a sub-Saharan African population using a public health approach The IMPAACT 2017 MOCHA study ev…

1
CVR Meets NIR DRAYMAN: International Mobility, Balancing Life & Career, and Choosing Lab Flooring 25:05

3M ago25:05

25:05

Listen to Dr Nir Drayman chat to Dr Mila Collados Rodriguez about his journey moving from Isreal to Chicago, to building his very own lab in California. Nir embraced the unexpected twists of life and found his passion for virology while working in systems biology labs. He speaks about the challenges of navigating career opportunities, spousal hirin…

1
How Primary Care Providers Can Expand Their Role in HBV Management 18:52

3M ago18:52

18:52

In this episode, learn how early and sustained HBV care can be enhanced by expanding the role of primary care providers in HBV management. Learn how to: Engage key stakeholders in the provision of HBV care Provide HBV management resources to support PCPs who are doing screening Consider specialty and primary care collaborations that empower PCPs …

1
CVR Meets NEREA IRIGOYEN: Ribosomal profiling, transitioning to independence and supporting Spanish researchers 31:31

3M ago31:31

31:31

Spanish virologist Nerea Irigoyen provides an inside look at her career with PhD students from the Castello Lab, Natasha Palmalux and Rozeena Arif. Nerea details her pioneering work using ribosomal profiling to uncover the complexities of viral gene expression, as well as her experiences transitioning to an independent group leader role. Irigoyen a…

1
Beyond Viral Suppression: A Case Study Addressing Internalized HIV Stigma 12:29

3M ago12:29

12:29

In this episode, Gregory Huhn, MD, MPHTM, uses a case study to explore the reasons healthcare professionals and people living with HIV may want to further optimize ART in the setting of viral suppression. To determine the best outcome for this case study, Dr Huhn discusses the reasons individuals may not be satisfied with daily oral ART and examine…

1
Linkage to Care After HBV Diagnosis: Sharing Session 3 16:54

4M ago16:54

16:54

In this episode, Maria Buti, MD, and her patient discuss opportunities to optimize care for people living with hepatitis B virus (HBV), including: Barriers to HBV screening, including patient- and provider-specific barriers (eg, lack of education, failure to disclose or discuss risk factors, perceived low risk, stigma) Applying CDC recommendations …

1
Key HIV Studies From CROI 2024 Influencing Clinical Practice 44:22

4M ago44:22

44:22

In this episode, Joseph J. Eron, Jr., MD, and Monica Gandhi, MD, MPH, discuss the key HIV studies from CROI 2024 that are influencing their clinical practice, including: New data surrounding long-acting ART, including: The CARES study of LA CAB + RPV in a Sub-Saharan African population using a public health approach The IMPAACT 2017 MOCHA study eva…

1
How to Implement Earlier Hepatitis B Treatment 21:27

4M ago21:27

21:27

In this episode, Mark S. Sulkowski, MD, FIDSA, FAASLD; Tatyana Kushner, MD, MSCE; Paul Y. Kwo, MD; and patient advocate Jacki Chen, PhD, consider barriers and solutions for more expansive HBV treatment in the United States. Topics include: Patient subgroups to consider for treatment outside guideline criteria Adverse event and cost-effectiveness co…

1
CVR Meets ANGELA RASMUSSEN: Toxic bosses, dealing with conflict and underrepresentation in science 56:04

4M ago56:04

56:04

Dr Angela Rasmussen travelled from the University of Saskatchewan to the CVR in September 2023, and sat down with Spyros Lytras and Kieran Lamb. Angela gives insight into dealing with toxic bosses, sustained research investments, empowering underrepresented groups of people, dealing with conflict and connecting with colleagues across disciplines th…

1
Empowering Patients With Education on HBV: Sharing Session 2 16:49

5M ago16:49

16:49

In this episode, Robert Wong, MD, MS, and a patient discuss opportunities to optimize care for people living with hepatitis B virus (HBV), including: Opportunities to improve patient education, including education for expectant mothers with HBV Potential cultural considerations that may result in delayed HBV diagnosis and care Stigma reduction with…

1
Switching HIV ART in Older People With Weight Gain and Cardiovascular Comorbidities 14:42

5M ago14:42

14:42

Listen to Roger Bedimo, MD, MS, FACP, discuss considerations for older people living with HIV, including: Polypharmacy and deprescribing The risk of cardiovascular events with various ART regimens Approaches for managing weight gain Presenter: Roger Bedimo, MD, MS, FACP Professor of Medicine Interim Director, Office of Global Health UT Southwestern…

1
CVR Meets Prof WENDY BARCLAY: Gender equality, open science & collaboration | Stoker Award Winner 31:40

5M ago31:40

31:40

Prof Wendy Barclay OBE, winner of the 11th Annual Sir Michael Stoker Award, sat down with Stephen Devlin and Anna Sims on her visit the the CVR. Wendy gives insight into building a career in virology, navigating the challenges of science communication in the digital age, the importance of widening your network and asking for help.🔗 Links More about…

1
Optimizing ART in Priority Populations: Initiating ART in Transgender Women 12:29

5M ago12:29

12:29

In this episode, Dr. Bedimo discusses best practices for individualized care in transgender women living with HIV, including: Providing services in a gender-affirmative care model Proactive counseling on drug-drug interactions with gender-affirming hormone therapy Strategies to reduce adverse events Presenter: Roger Bedimo, MD, MS, FACP Professor o…

1
Exploring HPV: What does it do and how can we protect ourselves from it? 10:31

5M ago10:31

10:31

For #HPVAwarenessDay, Anna Kirk, a PhD Researcher in the Graham Lab, takes a deep dive into Human Papillomavirus in our recent Research Goes Viral podcast. Anna explains the viral life cycle of HPV, how disruption of this cycle can lead to cancer, and how we can protect ourselves. #OneLessWorry

1
COVID-19 Case Challenges: Employing Outpatient Antivirals and Addressing Drug‒Drug Interactions 34:26

5M ago34:26

34:26

In this episode, Renslow Sherer, MD, and Trinh P. Vu, PharmD, BCIDP, discuss how to optimize the use of COVID-19 antivirals and how to navigate drug-drug interactions between COVID-19 treatments and a patient’s home medications. Their discussion includes: Current COVID-19 landscape COVID-19 testing and vaccination recommendations Treatment guidelin…

1
CVR Meets ANICE LOWEN: Glasgow Taxi Drivers, Flu Coinfection & Imposter Syndrome 1:04:04

6M ago1:04:04

1:04:04

Associate Professor Anice Lowen travelled all the way from Atlanta's Emory University to deliver the Richard M. Elliott Memorial Lecture at the recent Glasgow Virology Workshop. Anice completed her PhD at the CVR (then MRC Virology Unit) with Richard Elliott. We invited Anice along to chat with a couple of our PhD students, Stephen Devlin and Anna …

1
New Audio Updates: CCO Independent Conference Coverage of Hepatitis B at AASLD 2023 37:12

6M ago37:12

37:12

In this episode, Nancy Reau, MD, discusses new data on hepatitis B virus presented at AASLD 2023, including: Current therapies Studies 108 and 110: Factors Linked With Lack of Virologic Suppression After 8 Yr of TAF or TDF Kaiser Permanente Northern California: HCC or Death With TDF vs ETV for Chronic Hepatitis B Early vs Late Postpartum Cessation …

1
Reconsidering Your Approach: Strategies to Support PrEP Persistence and Reengagement 27:00

6M ago27:00

27:00

In this episode, LaRon E. Nelson, PhD, RN, FNP, FNAP, FNYAM, FAAN, discusses the role that healthcare professionals (HCPs) may be playing in their patients’ pre-exposure prophylaxis (PrEP) persistence and strategies to modify their approach to encourage persistence, from Clinical Care Options (CCO), including: Racial disparities in the PrEP care co…

1
My Journey With HBV and HDV: Sharing Session 1 15:19

6M ago15:19

15:19

In this episode, Nancy Reau, MD, and her patient discuss opportunities to optimize care for people living with hepatitis B virus and hepatitis delta virus, including: The importance of patient education along the care continuum Ensuring smooth transitions of care and communication between medical teams Screening hepatitis delta in persons with chro…

1
Professor Chloe Orkin - Getting Personal: Reassessing HIV Management to Better Individualize Treatment Across the Ages 53:54

6M ago53:54

53:54

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/YHX8…

1
Professor Chloe Orkin - Getting Personal: Reassessing HIV Management to Better Individualize Treatment Across the Ages 54:28

6M ago54:28

54:28

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/YHX8…

1
Shmuel Shoham, MD - Toward a Brighter Future for Preventing COVID-19 in Patients With Hematologic Malignancies: Leveraging the Power of Current Strategies and Next-Generation Agents 1:30:28

6M ago1:30:28

1:30:28

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/JXH865. CME credit will…

1
Shmuel Shoham, MD - Toward a Brighter Future for Preventing COVID-19 in Patients With Hematologic Malignancies: Leveraging the Power of Current Strategies and Next-Generation Agents 1:30:18

6M ago1:30:18

1:30:18

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/JXH865. CME credit will…

1
Why I Started and Why I Stayed on HIV PrEP 6:15

6M ago6:15

6:15

In this episode, David Saunders discusses the value of nonstigmatizing discussions between people using HIV pre-exposure prophylaxis (PrEP) and healthcare professionals, including: Encouraging accountability to individualize adherence strategies and improve persistence to PrEP Reducing stigma, discrimination, and prejudice in healthcare settings to…

1
Long-Acting PrEP: Strategies to Support PrEP Persistence and Reengagement 29:38

7M ago29:38

29:38

In this episode, Sarah M. Wood, MD, MS, discusses data and recommendations for long-acting pre-exposure prophylaxis (PrEP) as a strategy to support PrEP persistence and engagement for adolescents, including: The PrEP care continuum for adolescents System barriers to PrEP coverage and privacy concerns for adolescents The benefits and challenges of s…

1
RSV Vaccines in Adults: A Risk-Based Approach 9:40

7M ago9:40

9:40

In this episode, Angela Branche, MD, discusses RSV vaccines in older adults, including: Current Advisory Committee on Immunization Practices recommendations Risk factors associated with severe RSV disease, including RSV-related hospitalizations Approach to stratifying risk factors (eg, age, comorbidities) in determining which adults may benefit fro…

1
How to Implement Earlier Hepatitis B and Hepatitis Delta Screening 27:52

7M ago27:52

27:52

In this episode, Douglas Dieterich, MD, leads a panel discussion with Camilla S. Graham, MD, MPH, and Robert Wong, MD, MS, to consider advantages and barriers to universal screening for chronic HBV infection and universal HDV screening in adults with HBV in the United States. Topics include: Updated CDC recommendations for one-time universal screen…

1
Q&A on HIV PrEP: Episode 7 for Advanced Practice Providers 28:06

7M ago28:06

28:06

In this episode, Tavell L. Kindall, PhD, DNP, ARNP, FNP-BC, AACRN, AAHIVS, FAANP, and Anne Teitelman, PhD, FNP-BC, FANNP, FAAN, discuss key PrEP considerations for advanced practice providers in primary care settings, including: The importance of having PrEP navigators to help with logistics and be a point of contact for patients Where to find educ…

1
Mental Health Challenges: Dialogues on Optimizing Engagement in HIV Care 43:58

7M ago43:58

43:58

In this podcast episode, Mark Brennan-Ing, PhD, and Nina I. Martinez discuss mental health challenges in people living with HIV and much-needed strategies to overcome these challenges to optimize engagement in HIV care, including: The increased rates of mental health disorders and substance use among people living with HIV How mental health disorde…

1
Starting ART: Dialogues on Optimizing Engagement in HIV Care 42:27

7M ago42:27

42:27

In this podcast episode, Isolde Butler, MD, MPH, a healthcare professional caring for people living with HIV, and Marissa Gonzalez, an individual living with HIV, discuss strategies to improve healthcare professionals’ competencies in delivering optimal HIV care from the start to better support patients in overcoming barriers to sustained care enga…

1
Engagement in Care: Dialogues on Optimizing Engagement in HIV Care 30:03

7M ago30:03

30:03

In this podcast episode, Babafemi Taiwo, MBBS, and Vincent Crisostomo discuss the evolving treatment landscape for aging people living with HIV, encompassing the clinical and external resources necessary to support physical and psychosocial health. The topics discussed include: • Mindful prescribing and understanding the impact an HIV diagnosis can…

1
Providing Options for PrEP Reengagement: Strategies to Support PrEP Persistence and Reengagement 16:11

7M ago16:11

16:11

In this episode, Kevin Astle, PharmD, BCPS, BCACP, AAHIVP, CDCES, discusses data and recommendations for providing HIV prevention options as a strategy to support PrEP persistence and engagement, including: Postexposure prophylaxis (PEP) recommendations and the data for PEP-in-Pocket Offering PrEP to everyone who receives PEP Currently recommended …

1
Selected FXR Agonist PBC Studies: Conference Coverage of AASLD 17:36

7M ago17:36

17:36

During the 2023 American Association for the Study of Liver Diseases conference, exciting and important results from many primary biliary cholangitis (PBC) clinical trials were reported, including 3 late-breaking studies on the PPAR-δ agonist seladelpar, the dual PPAR agonist elafibranor, and the combination of the FXR agonist obeticholic acid and …

Podcasts που αξίζει να ακούσετε

Viral Hepatitis Podcasts

Podcasts που αξίζει να ακούσετε

Οδηγός γρήγορης αναφοράς